Radical research raises hopes for eye disease treatment for premature babies

October 2, 2017
Radical research raises hopes for eye disease treatment for premature babies
Dr Devy Deliyanti and Professor Jennifer Wilkinson-Berka. Credit: Monash University

Ground-breaking research by Monash University scientists has demonstrated the previously unknown existence of a disease-fighting immune cell in the eye and points to potential novel ways of treating eye disorders in premature babies and diabetic adults.

The scientists, led by Professor Jennifer Wilkinson-Berka in the Central Clinical School's new Department of Diabetes, were investigating improved ways of treating retinopathy of prematurity (ROP), which occurs in very small, prematurely born babies.

ROP is the main cause of vision loss and blindness in children globally. Current treatment is laser surgery on newborn babies to burn the damaged blood vessels that occur with the disorder, which also damages healthy cells.

The scientists found for the first time that regulatory T cells (Tregs) – disease-fighting – are present in the retina.

"People thought you couldn't actually have Tregs in eye tissue because the eye, like the brain, has a barrier that stopped them from entering. No one had ever described this before," Professor Wilkinson-Berka said.

"I thought there might be a weakness in the barrier."

The researchers confirmed this using animal models. They then boosted the to test whether they could repair damaged in the retina and found that ROP was significantly reduced.

The paper is published in the journal, Nature Communications.

Professor Wilkinson-Berka said improving treatments for babies with ROP was increasingly important as technology improved, saving increasingly small babies.

"We're seeing what's called a third epidemic of ROP as are getting smaller and smaller," she said.

Whereas born weighing less than 1500 grams have a 50 to 70 per cent risk of getting ROP, those under 750 grams have a 98 per cent chance they will be affected in varying degrees, she said.

A small clinical study will now be conducted in collaboration with the Royal Children's Hospital and Murdoch Children's Research Institute.

The research could have far-reaching implications for improving eye disease in people with .

"The same set of ideas are applicable," Professor Wilkinson-Berka said.

"An estimated 350 million people in the world today have diabetes and large numbers of these will have diabetic retinopathy."

Research into animal models of diabetes will be conducted in the Central Clinical School and clinical studies in patients with diabetic retinopathy performed at the Royal Victorian Eye and Ear Hospital and Centre for Eye Research Australia (CERA) with Associate Professor Lyndell Lim and Dr Sanjeewa Wickremasinghe, beginning in October.

"My hopes are that this sort of immune system therapy can be given to patients safely. One of the treatments we're investigating is a very safe thing to do. The therapies would not be a cure but would be added to current treatments to further improve them," Professor Wilkinson-Berka said.

Explore further: Study examines survival of very low birthweight babies

Related Stories

Study examines survival of very low birthweight babies

September 27, 2017
A new study published in Acta Paediatrica indicates that survival of babies born weighing ?500 g is poor despite advances in neonatal care.

Growth factor shown to protect the retina in early stage diabetes

February 2, 2017
Researchers from the Schepens Eye Research Institute of Massachusetts Eye and Ear have shown that a slight increase in transforming growth factor beta (TGF-β), which is present in preclinical animal models with diabetic ...

Researchers identify new target for abnormal blood vessel growth in the eyes

April 11, 2017
A team led by Massachusetts Eye and Ear researchers has identified a novel therapeutic target for retinal neovascularization, or abnormal blood vessel growth in the retina, a hallmark of advanced diabetic eye disease (proliferative ...

Nerve injury appears to be root of diabetes-related vision loss

March 24, 2016
Diabetes-related vision loss most often is blamed on blood vessel damage in and around the retina, but new research indicates that much of that vision loss may result from nerve cell injury that occurs long before any blood ...

Study suggests new way to prevent vision loss in diabetics and premature babies

March 22, 2017
Researchers at Bascom Palmer Eye Institute, part of the University of Miami Miller School of Medicine, have identified a new molecule that induces the formation of abnormal blood vessels in the eyes of diabetic mice. The ...

Loss of pericytes deteriorates retinal environment

May 16, 2017
Inside the eye, at the interface between blood vessels and the retina, lies a boundary that prevents harmful substances present in the blood from entering the retina. Researchers at the Center for Vascular Research, within ...

Recommended for you

Drinking hot tea every day linked to lower glaucoma risk

December 14, 2017
Drinking a cup of hot tea at least once a day may be linked to a significantly lower risk of developing the serious eye condition, glaucoma, finds a small study published online in the British Journal of Ophthalmology.

Newly published research provides new insight into how diabetes leads to retinopathy

December 7, 2017
An international team of scientists led by Professor Ingrid Fleming of Goethe University, Frankfurt, Germany, and including Professor Bruce Hammock of the University of California, Davis, provides new insight into the mechanism ...

Researchers use breakthrough technology to understand eclipse eye damage

December 7, 2017
In a first-of-its-kind study, Mount Sinai researchers are using adaptive optics (AO) to analyze retinal eye damage from the August solar eclipse on a cellular level. The research could help doctors develop a deeper understanding ...

Combating eye injuries with a reversible superglue seal

December 6, 2017
When a soldier sustains a traumatic eye injury on the battlefield, any delay in treatment may lead to permanent vision loss. With medical facilities potentially far away and no existing tools to prevent deterioration, medics ...

Trigger for most common form of vision loss discovered

November 27, 2017
In a major step forward in the battle against macular degeneration, the leading cause of vision loss among the elderly, researchers at the University of Virginia School of Medicine have discovered a critical trigger for the ...

Scientists engineer drug delivery device that treats glaucoma directly inside the eye

November 23, 2017
Glaucoma, which affects over 60 million people worldwide, can seem easy to treat: medicated eye drops can be used to ease the buildup of fluid in the eye that underlies the condition. If glaucoma is caught early, eye drops ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.